GBM has asked the SA government to accelerate the evaluation and registration of more affordable biosimilar medicines in South Africa.
All posts tagged 'MCC'
Government has signed the Medicines and Related Substances Amendment Act (2008) marking the official existence of the much-anticipated SAHPRA.
The CEO and Principal Officer at Profmed explains how the new medical device regulations will significantly change the existing regulatory regime.
The National Department of Health (NDoH) has delayed the launch of the much-anticipated South African Health Products Regulatory Agency (SAHPRA).
Acting Chief Operating Officer for Bonitas Medical Fund, Kenneth Marion, explains how generics could save consumers & medical aids millions of rands a year.
CEO of Pharma Dynamics, Erik Roos, explains that as generic penetration intensifies, more growth in the sector can be expected in the coming year.
ICDRA has kicked off today in Cape Town to address the hurdles that are preventing access to quality medical products, especially in developing countries.
CEO of Cipla Medpro, Paul Miller, explains why the leading pharmaceutical companies have a key role to play in the seemingly turbulent year ahead.
The Medicines Control Council has officially registered the use of a combination of two antiretroviral drugs as a form of PrEP medication.